PTS Diagnostics CEO and leadership

Mr. Chapman joined PTS Diagnostics in March of 2020 after 20+ years of management experience in the medical device industry with ARKRAY USA, Inc. and Medisys. He brings a wealth of knowledge and a successful track record of mergers and acquisitions, post-acquisition integration, global product launches, market identification, and strategic positioning. He is responsible for the overall leadership of PTS Diagnostics and ensuring that the organization continues to deliver on its mission of improving chronic disease management through point-of-care delivery. Mr. Chapman received a Bachelor of Arts from Sheffield University UK, LLM Commercial and Corporate Law from the University of London (SOAS), and LLM Health Law from Hamline Law School, St. Paul, MN. His international experience will serve as a boon to PTS Diagnostics across multiple global markets.

Mr. Morgan joins PTS Diagnostics with over 25 years of global finance and administration experience in life science and medical devices. Mark will oversee all Finance and Accounting functions, as well as Human Resources. Mark brings expertise in providing strategic leadership and significant experience supporting R&D, Supply Chain, and IT with companies including Pfizer, Bayer and Mylan Pharmaceuticals. Mark holds an undergraduate degree in Accounting from Indiana State University and MBA from Illinois State University. He has been published in financial journals multiple times and has authored a book. Mark is also on the Board of Directors of the Institute of Management Accountants (IMA).